ㅁ 18 September 2014
Congratulatory Remarks - Sang Woo Nam, Executive Secretary of OECD Korea Policy Centre
Session I. Key Issues in Pharmaceutical Policy and Financing 1. Pharmaceutical policy in Asia and the goals of the meeting - Presentation by Klara Tisocki (WHO WPRO) 2. Pharmaceutical policy in OECD countries - Presentation by Annalisa Belloni (OECD) 3. Pharmaceutical financing in Asia - Presentation by Soonman Kwon (Seoul National Univ. and WHO Collaborating Centre)
Session II. Pharmaceutical Policy and financing in Asia and the Pacific 1. Pharmaceutical expenditure and utilization (Chair: Prastuti Soewondo) - Presentation by Luca Lorenzoni (OECD)
- Country presentations (Cambodia, Mongolia) 2. Financing and benefit package (Chair: Taejin Lee) - Country presentations (Indonesia, Philippines, Thailand) 3. Pricing and reimbursement (Chair: Dennis Ross-Degnan) - Country presentations (Australia, Korea, Singapore)
4. Other key issues (e.g. rational use, procurement, quality (Chair: Libby Roughead) - Country presentations (Laos, Malaysia, Vietnam)
ㅁ 19 September 2014
Session III. Discussions and the Finalization of Template 1. Group discussions on the templates - 4 groups (Chairs: Philippines, Malaysia, Thailand, Singapore) 2. Reports from groups and discussions (Chair: Soonman Kwon)
3. The progress of Pharmaceutical Pricing and Reimbursement Policy (PPRI) Network by Sabine Wogler
(PPRI, Europe) and Discussions
Session IV. Future Plans / Chair: Klara Tisocki
|